Compare FLGT & RA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FLGT | RA |
|---|---|---|
| Founded | 2011 | 2016 |
| Country | United States | United States |
| Employees | N/A | 1260 |
| Industry | Medical Specialities | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 867.4M | 716.7M |
| IPO Year | 2016 | N/A |
| Metric | FLGT | RA |
|---|---|---|
| Price | $23.06 | $13.27 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $28.33 | N/A |
| AVG Volume (30 Days) | 196.7K | ★ 280.8K |
| Earning Date | 02-27-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 14.73% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $315,549,000.00 | N/A |
| Revenue This Year | $16.84 | N/A |
| Revenue Next Year | $9.74 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 13.61 | N/A |
| 52 Week Low | $14.57 | $11.89 |
| 52 Week High | $31.04 | $17.32 |
| Indicator | FLGT | RA |
|---|---|---|
| Relative Strength Index (RSI) | 22.58 | 67.60 |
| Support Level | $22.76 | $13.04 |
| Resistance Level | $26.74 | $13.16 |
| Average True Range (ATR) | 0.82 | 0.07 |
| MACD | -0.47 | 0.03 |
| Stochastic Oscillator | 5.13 | 95.45 |
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.
Brookfield Real Assets Income Fund Inc. is a diversified, closed-end management investment company. Its investment objective is to seek a high total return, through high current income and secondarily, through the growth of capital. The Fund seeks to achieve its investment objective by investing in the real asset class, which includes the following: Real Estate Securities; Infrastructure Securities; and Natural Resources Securities. The Firm manages separate accounts, registered funds, and opportunistic strategies for institutional and individual clients, including financial institutions, public and private pension plans, insurance companies, endowments and foundations, sovereign wealth funds, and high-net-worth investors.